INSM Q3 2018 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$30B

Q3 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$84M

Net Income

-$88M

EPS (Diluted)

$-1.14

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$65M

Free Cash Flow

-$67M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$662M

Total Liabilities

$370M

Stockholders' Equity

$291M

Cash & Equivalents

$568M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$84M	-$44M	-90.5%
Net Income	-$88M	-$45M	-94.2%